Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels

被引:102
作者
Religa, P
Cao, RH
Bjorndahl, M
Zhou, ZJ
Zhu, ZP
Cao, YH
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, Ctr Microbiol & Tumor Biol, Lab Angiogenesis Res, S-17177 Stockholm, Sweden
[2] Univ Hong Kong, Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China
[3] ImClone Syst, New York, NY USA
关键词
D O I
10.1182/blood-2005-01-0226
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bone marrow (BM)-derived circulating endothelial precursor cells (CEPCs) have been reported to incorporate into newly formed blood vessels under physiologic and pathologic conditions. However, it is unknown if CEPCs contribute to lymphangiogenesis. Here we show that in a corneal lymphangiogenesis model of irradiated mice reconstituted with enhanced green fluorescent protein (EGFP)-positive donor bone marrow cells, CEPCs are present in the newly formed lymphatic vessels. Depletion of bone marrow cells by irradiation remarkably suppressed lymphangiogenesis in corneas implanted with fibroblast growth factor-2 (FGF-2). Further, transplantation of isolated EGFP-positive/vascular endothelial growth factor receptor-3-positive (EGFP(+)NEGFR3(+)) or EGFP(+)/VEGFR-2(+)cell populations resulted in incorporation of EGFP(+) cells into the newly formed lymphatic vessels. EGFP(+)/ CEPCs were also present in peritumoral lymphatic vessels of a fibrosarcoma. These data suggest that BM-derived CEPCs may play a role in "lymphvasculogenesis."
引用
收藏
页码:4184 / 4190
页数:7
相关论文
共 29 条
[1]   Molecular mechanisms of lymphangiogenesis in health and disease [J].
Alitalo, K ;
Carmeliet, P .
CANCER CELL, 2002, 1 (03) :219-227
[2]   Endothelial progenitor cells for postnatal vasculogenesis [J].
Asahara, T ;
Kawamoto, A .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (03) :C572-C579
[3]   PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis [J].
Cao, RH ;
Björndahl, MA ;
Religa, P ;
Clasper, S ;
Garvin, S ;
Galter, D ;
Meister, B ;
Ikomi, F ;
Tritsaris, K ;
Dissing, S ;
Ohhashi, T ;
Jackson, DG ;
Cao, YH .
CANCER CELL, 2004, 6 (04) :333-345
[4]   Lymphangiogenesis - New mechanisms [J].
Chang, L ;
Kaipainen, A ;
Folkman, J .
LYMPHATIC CONTINUUM: LYMPHATIC BIOLOGY AND DISEASE, 2002, 979 :111-119
[5]   Dose-dependent response of FGF-2 for lymphangiogenesis [J].
Chang, LK ;
Garcia-Cardeña, G ;
Farnebo, F ;
Fannon, M ;
Chen, EJ ;
Butterfield, C ;
Moses, MA ;
Mulligan, RC ;
Folkman, J ;
Kaipainen, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) :11658-11663
[6]  
Cursiefen C, 2002, INVEST OPHTH VIS SCI, V43, P2127
[7]   VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment [J].
Cursiefen, C ;
Chen, L ;
Borges, LP ;
Jackson, D ;
Cao, JT ;
Radziejewski, C ;
D'Amore, PA ;
Dana, MR ;
Wiegand, SJ ;
Streilein, JW .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (07) :1040-1050
[8]   Tumor lymphangiogenesis - A novel prognostic indicator for cutaneous melanoma metastasis and survival [J].
Dadras, SS ;
Paul, T ;
Bertoncini, J ;
Brown, LF ;
Muzikansky, A ;
Jackson, DG ;
Ellwanger, U ;
Garbe, C ;
Mihm, MC ;
Detmar, M .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) :1951-1960
[9]   Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy [J].
Dvorak, HF .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) :4368-4380
[10]   Activated Fps/Fes partially rescues the in vivo developmental potential of Flk1-deficient vascular progenitor cells [J].
Haigh, JJ ;
Ema, M ;
Haigh, K ;
Gertsenstein, M ;
Greer, P ;
Rossant, J ;
Nagy, A ;
Wagner, EF .
BLOOD, 2004, 103 (03) :912-920